BTLA Antikörper (C-Term)
Kurzübersicht für BTLA Antikörper (C-Term) (ABIN334365)
Target
Alle BTLA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- BTLA
-
Sequenz
- KEAPTEYASI CVRS
-
Spezifität
- This antibody is expected to recognize both reported isoforms (NP_861445.3, NP_001078826.1).
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence KEAPTEYASICVRS, from the C Terminus of the protein sequence according to NP_861445.3, NP_001078826.1.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Western Blot: Approx. 35 kDa band observed in Mouse Spleen lysates (calculated MW of 32.8 kDa according to Human NP_861445.3 and of 34.2 kDa according to Mouse NP_001032808.2). Recommended concentration: 1-3 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:4000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Andere Bezeichnung
- BTLA
-
Hintergrund
- BTLA, B and T lymphocyte associated, BTLA1, CD272, FLJ16065, MGC129743, B and T lymphocyte attenuator
-
Gen-ID
- 151888, 208154, 407756
-
NCBI Accession
- NP_861445, NP_001078826
-
Pathways
- Cancer Immune Checkpoints
Target
-